Sunday, February 25, 2018
Tags Drugmakers

Tag: Drugmakers

Roche to Buy Flatiron Health for $1.9 Billion to Expand Cancer...

(Reuters)  Swiss drugmaker Roche Holding AG  said on Thursday it would buy the rest of U.S. cancer data company Flatiron Health for $1.9 billion to...

OxyContin Maker Stops Promoting Opioids, Cuts Sales Staff

(Reuters) OxyContin maker Purdue Pharma LP said on Saturday that it has cut its sales force in half and will stop promoting opioids to physicians,...

Teva Warns on 2018 Profit, May Face Migraine Drug Delays

By Tova Cohen and Steven Scheer TEL AVIV (Reuters) Teva Pharmaceutical Industries on Thursday said its 2018 results would be weaker than expected and that...

GlaxoSmithKline Sees Light at End of Advair Tunnel

By Ben Hirschler LONDON (Reuters) GlaxoSmithKline sees growth strengthening over the next few years as the drugmaker weathers increased competition in its core respiratory and...

Roche Notches Fresh Win amid Crowd of Immunotherapy Cocktails

By John Miller ZURICH (Reuters) Roche's Tecentriq mixed with an older drug cut the risk of death in kidney cancer, marking another win for the Swiss...

Philippines Says Anti-Dengue Vaccine May Be Connected to Three Deaths

By Manuel Mogato MANILA (Reuters) The Philippines said on Friday the anti-dengue vaccine Dengvaxia may be connected to three deaths in the country, according to a...
banner
facebook